Literature DB >> 15331697

A mutant of Sindbis virus which is able to replicate in cells with reduced CTP makes a replicase/transcriptase with a decreased Km for CTP.

Mei-Ling Li1, Yen-Huei Lin, H Anne Simmonds, Victor Stollar.   

Abstract

We reported earlier the isolation and characterization of a Sindbis virus mutant, SV(PZF), that can grow in mosquito cells treated with pyrazofurin (PZF), a compound that interferes with pyrimidine biosynthesis (Y. H. Lin, P. Yadav, R. Ravatn, and V. Stollar, Virology 272:61-71, 2000; Y. H. Lin, H. A. Simmonds, and V. Stollar, Virology 292:78-86, 2002). Three amino acid changes in nsP4, the viral RNA polymerase, were required to produce this phenotype. We now describe a mutant of Sindbis virus, SVCPC, that is resistant to cyclopentenylcytosine (CPC), a compound that interferes only with the synthesis of CTP. Thus, in contrast to SVPZF, which was selected for its ability to grow in mosquito cells with low levels of UTP and CTP, SVCPC was selected for its ability to grow in cells in which only the level of CTP was reduced. Although SV(PZF) was cross-resistant to CPC, SVCPC was not resistant to PZF. Only one amino acid change in nsP4, Leu 585 to Phe, was required for the CPC resistance phenotype. The viral replicase/transcriptase generated in SVCPC-infected mosquito cells had a lower Km for CTP (but not for UTP) than did the enzyme made in SVSTD-infected mosquito cells. SV(PZF) and SVCPC represent the first examples of viral mutants selected for the ability to grow in cells with low levels of ribonucleoside triphosphates (rNTPs). Further study of these mutants and determination of the structure of nsP4 should demonstrate how alterations in an RNA-dependent RNA polymerase permit it to function in cells with abnormally low levels of rNTPs. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331697      PMCID: PMC515026          DOI: 10.1128/JVI.78.18.9645-9651.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Identification of a novel function of the alphavirus capping apparatus. RNA 5'-triphosphatase activity of Nsp2.

Authors:  L Vasiljeva; A Merits; P Auvinen; L Kääriäinen
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

2.  Sialic acid contents of sindbis virus from vertebrate and mosquito cells. Equivalence of biological and immunological viral properties.

Authors:  V Stollar; B D Stollar; R Koo; K A Harrap; R W Schlesinger
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

3.  A mutant of Sindbis virus that is resistant to pyrazofurin encodes an altered RNA polymerase.

Authors:  Y H Lin; P Yadav; R Ravatn; V Stollar
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

4.  Defective-interfering particles of Sindbis virus. II. Homologous interference.

Authors:  T E Shenk; V Stollar
Journal:  Virology       Date:  1973-10       Impact factor: 3.616

5.  The effects of adenosine and guanosine on the replication of Sindbis and vesicular stomatitis viruses in Aedes albopictus cells.

Authors:  V Stollar; F Malinoski
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

6.  Alphavirus minus-strand RNA synthesis: identification of a role for Arg183 of the nsP4 polymerase.

Authors:  Cori L Fata; Stanley G Sawicki; Dorothea L Sawicki
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors.

Authors:  L D Fairbanks; M Bofill; K Ruckemann; H A Simmonds
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

8.  T-lymphocytes from AIDS patients are unable to synthesize ribonucleotides de novo in response to mitogenic stimulation. Impaired pyrimidine responses are already evident at early stages of HIV-1 infection.

Authors:  M Bofill; L D Fairbanks; K Ruckemann; M Lipman; H A Simmonds
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

9.  Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Q May Wang; Michelle A Hockman; Kirk Staschke; Robert B Johnson; Katharine A Case; Jirong Lu; Steve Parsons; Faming Zhang; Radhakrishnan Rathnachalam; Karla Kirkegaard; Joseph M Colacino
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Template-dependent initiation of Sindbis virus RNA replication in vitro.

Authors:  J A Lemm; A Bergqvist; C M Read; C M Rice
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  5 in total

1.  In vitro synthesis of Sindbis virus genomic and subgenomic RNAs: influence of nsP4 mutations and nucleoside triphosphate concentrations.

Authors:  Mei-Ling Li; Hongtao Wang; Victor Stollar
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

2.  Synthesis of genomic and subgenomic RNA in mosquito cells infected with two Sindbis virus nsP4 mutants: influence of intracellular nucleoside triphosphate concentrations.

Authors:  Mei-Ling Li; Tzu-Yu Kwan; H Anne Simmonds; Victor Stollar
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

3.  Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses.

Authors:  Weiping Peng; Daniel C Peltier; Martha J Larsen; Paul D Kirchhoff; Scott D Larsen; Richard R Neubig; David J Miller
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

4.  Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.

Authors:  Phillip C Delekta; Craig J Dobry; Janice A Sindac; Scott J Barraza; Pennelope K Blakely; Jianming Xiang; Paul D Kirchhoff; Richard F Keep; David N Irani; Scott D Larsen; David J Miller
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

Review 5.  Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control.

Authors:  E A Gould; B Coutard; H Malet; B Morin; S Jamal; S Weaver; A Gorbalenya; G Moureau; C Baronti; I Delogu; N Forrester; M Khasnatinov; T Gritsun; X de Lamballerie; B Canard
Journal:  Antiviral Res       Date:  2009-07-16       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.